Retraction notice to "New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities" [Biomedicine & Pharmacotherapy 141 (2021) 111824] - 23/04/26
Doi : 10.1016/j.biopha.2026.119228
Milad Ashrafizadeh a, b, Sepideh Mirzaei c, Farid Hashemi d, Ali Zarrabi b, Amirhossein Zabolian e, Hossein Saleki e, Seyed Omid Sharifzadeh e, Leyla Soleymani f, Salman Daneshi g, Kiavash Hushmandi h, Haroon Khan i, Alan Prem Kumar j, k, Amir Reza Aref l, m, Saeed Samarghandian n, ⁎
a Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, Üniversite Caddesi No. 27, Orhanlı, Tuzla, 34956 Istanbul, Turkey
b Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla, 34956 Istanbul, Turkey
c Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran
d Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
e Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
f Department of Biology, Faculty of Science, Urmia University, Urmia, Iran
g Department of Public Health, School of Health, Jiroft University of Medical Sciences, Jiroft, Iran
h Department of Food Hygiene and Quality Control, Division of epidemiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
i Department of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan
j Cancer Science Institute of Singapore and Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117599, Singapore
k NUS Centre for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore
l Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
m Vice President at Translational Sciences, Xsphera Biosciences Inc. 6 Tide Street, Boston, MA 02210, USA
n Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran
⁎ Corresponding author.
Le texte complet de cet article est disponible en PDF.
© 2026
Publié par Elsevier Masson SAS.
Vol 198
Article 119228- mai 2026 Retour au numéro
Article précédent
- Retraction notice to "Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms" [Biomedicine & Pharmacotherapy 162 (2023) 114585]
- Yue Hu, Lin Yang, Yu Lai
- Retraction notice to "MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma" [Biomedicine & Pharmacotherapy 117 (2019) 108998]
- Minhui Zhu, Caiyun Zhang, Donghui Chen, Shicai Chen, Hongliang Zheng
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?